Komori
Mochida Pharmaceutical (4534) · InitiativeRestated

Directors' and Officers' Liability Insurance Policy

First written in FY2021. 3 of 4 entries say "Restated". Latest entry: FY2026.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20262021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Governance Response Through Directors and Officers Liability InsuranceA theme 882 companies write about · 0 as a headwind · 735 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 882 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The Company has entered into an officers and directors liability insurance agreement with an insurance company, covering the directors, corporate auditors and executive officers of the Company and 6 subsidiaries (Mochida Pharmaceutical Plant Co., Ltd., Mochida Healthcare Co., Ltd., Mochida Pharmaceutical Sales Co., Ltd., Mochida Heartful Service Co., Ltd., Technofine Co., Ltd., and Mochida Medical USA, Inc.) as insured persons, as stipulated in Article 430-3, Paragraph 1 of the Companies Act.」

    The company continues its officers and directors liability insurance agreement covering the officers and others of the Company and 6 subsidiaries.
  2. FY2025RestatedAnnual report

    「The Company has entered into an officers and directors liability insurance agreement with an insurance company, covering the directors, corporate auditors and executive officers of the Company and 5 subsidiaries as insured persons, as stipulated in Article 430-3, Paragraph 1 of the Companies Act.」

    The company continues its officers and directors liability insurance agreement covering the officers and others of the Company and 5 subsidiaries.
  3. FY2022RestatedAnnual report

    「The Company has entered into an officers and directors liability insurance agreement with an insurance company, covering the directors, corporate auditors and executive officers of the Company and 5 subsidiaries as insured persons, as stipulated in Article 430-3, Paragraph 1 of the Companies Act.」

    The company continues its officers and directors liability insurance agreement covering the officers and others of the Company and 5 subsidiaries.
  4. FY2021First statedAnnual report

    「The Company has entered into an officers and directors liability insurance agreement with an insurance company, covering the directors, corporate auditors and executive officers of the Company and 5 subsidiaries as insured persons, as stipulated in Article 430-3, Paragraph 1 of the Companies Act.」

    The company discloses for the first time an officers and directors liability insurance agreement covering the directors, corporate auditors, executive officers and others of the Company and its subsidiaries.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Directors' and Officers' Liability Insurance Policy | Mochida Pharmaceutical Co.,Ltd. (4534) | Komori